Medicure Inc MCUJF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MCUJF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.79
- Day Range
- $0.74–0.85
- 52-Week Range
- $0.74–1.26
- Bid/Ask
- $0.75 / $0.88
- Market Cap
- $7.72 Mil
- Volume/Avg
- 12,400 / 4,355
Key Statistics
- Price/Earnings (Normalized)
- 22.69
- Price/Sales
- 0.48
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 25
- Website
- https://www.medicure.com
Valuation
|
Metric
|
MCUJF
|
|---|---|
Price/Earnings (Normalized) | 22.69 |
Price/Book Value | 0.51 |
Price/Sales | 0.48 |
Price/Cash Flow | 6.47 |
Price/Earnings
MCUJF
Financial Strength
|
Metric
|
MCUJF
|
|---|---|
Quick Ratio | 1.41 |
Current Ratio | 1.92 |
Interest Coverage | −47.60 |
Quick Ratio
MCUJF
Profitability
|
Metric
|
MCUJF
|
|---|---|
Return on Assets (Normalized) | 2.74% |
Return on Equity (Normalized) | 3.80% |
Return on Invested Capital (Normalized) | 3.04% |
Return on Assets
MCUJF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zjlvbgjvc | Blcy | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Gqlmbrqzz | Yhjkfwp | $68.1 Bil | |
HLN
| Haleon PLC ADR | Jznxljsg | Csypm | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Fjcytgtch | Fkv | $14.3 Bil | |
VTRS
| Viatris Inc | Hymhhkx | Sdvj | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xrbnyjqbq | Hxy | $12.0 Bil | |
CTLT
| Catalent Inc | Lphkrrqsh | Xnzzff | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Lkxtxgpm | Qclr | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rbhcwmwx | Qpm | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jpzghvlwv | Ysngft | $3.4 Bil |